TR-14035

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTR-14035
Drug Alias NameSB-683698TR-14035
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-4/beta-7 antagonistsIntegrin alpha-4/beta-1 antagonists
TargetsIntegrin alpha-4/beta-1Integrin alpha-4/beta-7
Therapy Area/IndicationsMultiple SclerosisAsthmaArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMitsubishi Tanabe Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline PlcMitsubishi Tanabe Pharma
Active IndicationsN/A
Inactive IndicationsMultiple SclerosisAsthmaArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A